Stockreport

Merrimack Pharmaceuticals Announces Notification of Plan to Voluntary Delist Common Stock on NASDAQ Subject to Receipt of Stockholder Approval of Plan of Dissolution

Merrimack Pharmaceuticals, Inc.  (MACK) 
Last merrimack pharmaceuticals, inc. earnings: 3/6 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.merrimack.com/investor-relations
PDF Company Updates Potential Range of Initial Liquidating Distribution and Additional Dividend Information CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merrimack Pharmaceuticals, [Read more]